Science Explorer Back to mapMap
Discussion
Researcher · Mútua Terrassa · Spain

Marta Santaliestra

Marta Santaliestra publishes mostly in Genetics, Hematology and Molecular Biology, on topics such as Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments and Kruppel-like factors research.

ORCID 0000-0002-8293-5779 OpenAlex
World rank
#4,414,887
of 7,710,434 ranked researchers
Rank in Spain
#101,642
of 204,306
Works
20
Citations
81
Citations per work
4.1
h-index
5
i10-index 2Top 89% in Genetics (Medicine)
Marta Santaliestra

What does Marta Santaliestra research?

Marta Santaliestra's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 16 works · 79.3% of their workMedicine: 16 works · 79.3% of their workGenetics: 7 works · 32.8% of their workHematology: 6 works · 29.3% of their workOncology: 1 works · 6.9% of their workPulmonary and Respiratory Medicine: 1 works · 6.9% of their workRheumatology: 1 works · 3.4% of their workEverything else: 2 works · 10.4% of their workLife Sciences: 2 works · 10.3% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 10.3% of their workMolecular Biology: 2 works · 10.3% of their workTHEIR WORKMartaSantaliestra20works
Life Sciences10%Health Sciences79%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1679.3%
  2. Everything else210.4%
    1. Biochemistry, Genetics and Molecular Biology210.3%
  1. 1Genetics33% of their works
  2. 2Hematology29% of their works
  3. 3Molecular Biology10% of their works
  4. 4Pulmonary and Respiratory Medicine7% of their works
  5. 5Oncology7% of their works
  6. 6Rheumatology3% of their works

Research topics

Which keywords describe Marta Santaliestra's research?

The keywords of their largest research topics: JAK2 Mutation, Myelofibrosis, BCR-ABL, Imatinib, Prognostic Factors, Krüppel-like Factors, Transcriptional Regulation and Acute Myeloid Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. JAK2 Mutation131 topic
  2. Myelofibrosis131 topic
  3. BCR-ABL101 topic
  4. Imatinib101 topic
  5. Prognostic Factors62 topics
  6. Krüppel-like Factors41 topic
  7. Transcriptional Regulation41 topic
  8. AML31 topic
  9. Acute Myeloid Leukemia31 topic
  10. Breast Cancer31 topic
  11. Chronic Lymphocytic Leukemia31 topic
  12. EGFR Mutations31 topic
  13. Genomic Aberrations31 topic
  14. HER231 topic
  15. Sickle-cell Disease31 topic
  16. Targeted Therapy31 topic
  17. Thalassemia31 topic

Where does Marta Santaliestra work?

Marta Santaliestra's main affiliation in the publication record is Mútua Terrassa, Spain.

How many publications and citations does Marta Santaliestra have?

OpenAlex counts 20 works and 81 citations for Marta Santaliestra, an h-index of 5, ranking #4,414,887 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marta Santaliestra. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.